As part of an overall effort at Kentucky-based Baptist Health to centralize supply chain activities, leaders looked at supply inventory systems and delivery methods to reduce costs, improve par optimization and enhance efficiency.
Prior to 2013, Kentucky-based Baptist Health had a decentralized supply management structure for med/surg supplies. Although purchasing was done using one consolidated item master, efforts to standardize products across the system were difficult, which meant each hospital could order its own...
Looking Beyond Price - The supply chain team plays a critical role in the overall financial health of a healthcare organization. As non-labor supply expenses continue to rise, mostly due to new product technology, organizations must look for ways to control costs and combat pricing variations of up...
Fully integrating Amazon Business into a Washington state hospital's supply-chain operations has taken the hassle and some expense out of tedious procurement processes.
Many providers cite savings on services and supply chain as a sizable factor driving their mergers and acquisitions. But a new paper shows bundling purchases and standardization don't save as much as they think.
The commerce giant could give traditional industry vendors a run for their money as it eyes electronic health records, retail clinics and other mainstays of healthcare delivery.
The Teamsters union is urging its fellow McKesson Corp. shareholders to vote against the re-election of the drug distributor's audit committee chair at its annual shareholder meeting on July 25.
Walgreens Boots Alliance on Thursday reported that third-quarter earnings jumped more than 15%. But its stock price fell more than 9% after Amazon announced it's buying PillPack, an online pharmacy that delivers prescriptions.
Sixty-two percent of health system executives support Amazon's growing presence in the medical supply sector and nearly the same amount said the company could successfully deliver supplies faster and at a lower price, according to a new survey.
Generic-drug manufacturers, which source most of their active ingredients from China and India, could be hit the hardest by President Donald Trump's proposed tariffs, experts said.
The test doesn't detect concussions and the approval won't immediately change how patients with suspected concussions are treated. But it allows Banyan Biomarkers to commercialize its test, giving the company an early lead in the race to find a way to diagnose concussions.
Tired of paying intermediaries' price markups, some providers are getting better deals elsewhere.